Abstract
The first line treatment for glaucoma, a chronic condition which is the second biggest cause of irreversible vision loss in the globe, is self-administered topical ocular hypotensive drops. Medication adherence is a major issue in the management of glaucoma patients. Numerous obstacles to patients’ compliance have been discovered in the literature, ranging from elements related to the drug delivered, interactions between patients and their doctors, and elements related to patients’ behaviours and lifestyles. Patients who do not take their medications as directed run the danger of not getting the expected results, which frequently results in irreversible vision loss. We have reviewed available literature regarding patient compliance in the disease management of glaucoma and formulated a few recommendations based on the latest research in the field to practically apply in practice to increase compliance in this chronic condition.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Global Journal of Cataract Surgery and Research in Ophthalmology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
